Defence Therapeutics Inc.
Defence Therapeutics Inc.
Indice CSE:
CSE CompositeDevise:
CAD Defence Therapeutics Inc. is a biotechnology company engaged in the business of research and development, focusing on enhancing delivery of tumor-/ and infectious disease-specific therapeutics. The principal business carried on is the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.
Defence Therapeutics Inc. (DTC)
(%)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Information d'entreprise
Addresse
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaTéléphone
604-753-8834Courriel
sebas.plouffe@gmail.comURL
https://defencetherapeutics.comDate d’inscription à la cote
Vendredi, mai 7, 2021
Agent de transfert
Computershare Investor Services Inc.SEDAR Information
Type de dossier
Tout
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
1615, 200 Burrard St.
Vancouver, BC V6C 3L6
CanadaTéléphone
604-753-8834Courriel
sebas.plouffe@gmail.comURL
https://defencetherapeutics.comDate d’inscription à la cote
Vendredi, mai 7, 2021
Agent de transfert
Computershare Investor Services Inc.Capitalisation
Capitalisation:
54725370Réservé à l'émission:
6437785Company Officers
P. Joseph Meagher, Chief Financial Officer
Sebastien Plouffe, President and Chief Executive Officer
Arnab De, CFO
